186 Distinct immune signatures predicting clinical response to PD-1 blockade therapy in gynecological cancers revealed by high-dimensional immune profiling

by Dmitriy Zamarin, Claire Friedman, Yuki Muroyama, Sasikanth Manne, Alexandar Huang, Divij Mathew, Lakshmi Chilukuri, Allison Greenplate, Takuya Ohtani, John Wherry
Published 2020-11-01

Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL.

by Sarah J Stein, Ethan A Mack, Kelly S Rome, Kostandin V Pajcini, Takuya Ohtani, Lanwei Xu, Yunlei Li, Jules P P Meijerink, Robert B Faryabi, Warren S Pear
Published 2016-01-01

PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185erbB2/neu Tumor Immunotherapy

by Yasuhiro Nagai, Mei Q. Ji, Fuxiang Zhu, Yan Xiao, Yukinori Tanaka, Taku Kambayashi, Shigeyoshi Fujimoto, Michael M. Goldberg, Hongtao Zhang, Bin Li, Takuya Ohtani, Mark I. Greene
Published 2019-02-01

Dynamic Interactions between TIP60 and p300 Regulate FOXP3 Function through a Structural Switch Defined by a Single Lysine on TIP60

by Yan Xiao, Yasuhiro Nagai, Guoping Deng, Takuya Ohtani, Zhiqiang Zhu, Zhaocai Zhou, Hongtao Zhang, Mei Q. Ji, John W. Lough, Arabinda Samanta, Wayne W. Hancock, Mark I. Greene
Published 2014-06-01